Subscribe to RSS
DOI: 10.1055/a-2383-2527
A Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor on 18F-FDG PET/CT
Abstract
A 65-year-old man, who denied a smoking history, presented with chest distress and pain persisting for over a week. A contrast-enhanced chest CT scan revealed a large irregular mass in the right thoracic cavity with heterogeneous enhancement. The 18F-FDG PET/CT showed a large mass in the right thoracic cavity with heterogeneous markedly high FDG uptake. The patient subsequently underwent a bronchoscopic-guided mucosal biopsy at the opening of the right upper lobe. The histological and immunohistochemical findings were consistent with thoracic SMARCA4-deficient undifferentiated tumor.
Publication History
Received: 31 July 2024
Accepted: 06 August 2024
Article published online:
20 November 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Nambirajan A, Jain D. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor. Semin Diagn Pathol 2021; 38: 83-89
- 2 Jiang J, Chen Z, Gong J. et al. Thoracic SMARCA4-deficient undifferentiated tumor. Discov Oncol 2023; 14: 51
- 3 Nicholson AG, Tsao MS, Beasley MB. et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol 2022; 17: 362-387
- 4 Perret R, Chalabreysse L, Watson S. et al. SMARCA4-deficient thoracic sarcomas: clinicopathologic study of 30 cases with an emphasis on their nosology and differential diagnoses. Am J Surg Pathol 2019; 43: 455-465
- 5 Crombé A, Alberti N, Villard N. et al. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients. Eur Radiol 2019; 29: 4730-4741
- 6 Wu H, Zhou Y, Dong A. et al. Thoracic SMARCA4-Deficient Undifferentiated Tumor Mimicking Malignant Pleural Mesothelioma on FDG PET/CT. Clin Nucl Med 2024;
- 7 Kakkar A, Ashraf SF, Rathor A. et al. SMARCA4/BRG1-Deficient Sinonasal Carcinoma. Arch Pathol Lab Med 2022; 146 (09) 1122-1130
- 8 Wang J, Elghawy O, Kurpiel B. et al. Diagnosis and management of gastrointestinal SMARCA4-deficient undifferentiated tumors. Clin J Gastroenterol 2023; 16 (06) 807-814
- 9 Meda Y, Miyake H, Nagai H. et al. SMARCA4-deficient rectal carcinoma with a sarcomatoid component: a case report. Clin J Gastroenterol 2022; 15 (02) 419-426
- 10 Ching D, Ruba S, Soma A. et al. SMARCA4-deficient anaplastic carcinoma arising in a primary retroperitoneal mucinous adenocarcinoma. Pathology 2022; 54 (03) 376-378
- 11 Huang R, Chen L, Pan C. et al. SMARCA4-deficient dedifferentiated endometrioid carcinoma: a case report. Asian J Surg 2023; 46 (12) 5484-5485
- 12 Romero OA, Vilarrubi A, Alburquerque-Bejar JJ. et al. SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade. Nat Commun 2021; 12 (01) 4319
- 13 Guo J, Liao Z, Chen Q. et al. FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor. Clin Nucl Med 2023; 48 (12) 1111-1113
- 14 Chen X, Chen G, Li Q. et al. Thoracic SMARCA4-Deficient Undifferentiated Tumor Mimicking a Pleural Mesothelioma on 18F-FDG PET/CT. Clin Nucl Med 2024;